Related Experiment Video

Updated: Apr 3, 2026

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
13:35

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

Published on: March 1, 2018

15.5K

Study of the safety of methylphenidate: Focus on nephrotoxicity aspects

Luiza Herbene Macedo Soares Salviano1, Maria Isabel Linhares2, Klistenes Alves de Lima3

  • 1Postgraduation Program in Development and Technological Innovation in Medicines (PPGDITM), Federal University of Ceará (UFC), Brazil.

Life Sciences
|September 27, 2015
PubMed
Abstract

Insights

Methylphenidate (MPD) may impact kidney function, reducing urinary flow and sodium transport. Further research is needed to understand potential nephrotoxicity risks associated with this ADHD medication.

Area of Science:

  • Pharmacology
  • Nephrology
  • Toxicology

Background:

  • Methylphenidate (MPD) is a widely prescribed medication for Attention Deficit Hyperactivity Disorder (ADHD).
  • Concerns exist regarding the appropriate use of MPD and its potential adverse effects, particularly on kidney function.
  • Limited data is available on the nephrotoxic potential of MPD.

Purpose of the Study:

  • To investigate the safety of Methylphenidate (MPD).
  • To assess the potential effects of MPD on renal function and identify possible nephrotoxicity.

Main Methods:

  • Utilized in vivo and in vitro experimental models to examine MPD's impact on the renal perfusion system and tubular cells.
  • Conducted experiments involving isolated kidney perfusion and canine renal epithelial cell line (MDCK) culture.

Main Results:

  • In vivo studies showed no significant changes in urea, creatinine, or electrolyte excretion 24-48 hours post-MPD administration.
  • Isolated kidney perfusion revealed that MPD significantly decreased urinary flow, glomerular filtration rate, and tubular sodium transport.
  • MPD did not exhibit cytotoxicity or cause histopathological alterations in MDCK cell cultures.

Conclusions:

  • Findings suggest MPD may possess nephrotoxic potential by impairing glomerular activity, reducing urinary flow, and altering sodium transport.
  • Further investigation is warranted to fully elucidate these renal effects and mitigate potential risks associated with MPD treatment.
Keywords:
MethylphenidateNephrotoxicityRenal perfusion

More Related Videos

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones06:06

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

27.1K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

8.0K

Related Concept Videos

Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
171
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
377
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
182
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
491
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
583
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
313